Ranger Investment Management L.P. Purchases Shares of 319,253 HealthEquity, Inc. $HQY

Key Points

• Ranger Investment Management acquired 319,253 HealthEquity shares worth approximately $28.8 million, giving it a 0.38% stake. Institutional investors collectively own 99.55% of the company.
• Analysts maintain a broadly positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $110.93; BTIG recently raised its target to $115.
• HealthEquity exceeded quarterly expectations with adjusted EPS of $1.24 versus the $1.11 estimate and revenue of $354.64 million, up 7.2% year over year. The stock opened at $105.41, near its 52-week high of $107.62.

Ranger Investment Management L.P. acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 319,253 shares of the company's stock, valued at approximately $28,835,000. HealthEquity makes up approximately 1.8% of Ranger Investment Management L.P.'s holdings, making the stock its 16th biggest position. Ranger Investment Management L.P. owned 0.38% of HealthEquity as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Acumen Wealth Advisors LLC acquired a new position in HealthEquity in the fourth quarter worth about $27,000. Aster Capital Management DIFC Ltd bought a new position in HealthEquity during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd boosted its holdings in HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company's stock valued at $28,000 after purchasing an additional 293 shares in the last quarter. Leonteq Securities AG boosted its holdings in HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company's stock valued at $32,000 after purchasing an additional 235 shares in the last quarter. Finally, Silvant Capital Management LLC bought a new stake in shares of HealthEquity in the 2nd quarter valued at approximately $35,000. 99.55% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on HQY. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a report on Saturday. Barrington Research reaffirmed an "outperform" rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. BTIG Research upped their price target on HealthEquity from $110.00 to $115.00 and gave the company a "buy" rating in a research report on Friday, July 24th. KeyCorp reiterated an "overweight" rating on shares of HealthEquity in a research note on Tuesday, May 26th. Finally, Weiss Ratings raised HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a report on Friday, June 5th. Eleven investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $110.93.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the firm's stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. This trade represents a 7.60% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the business's stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the transaction, the executive vice president directly owned 52,244 shares of the company's stock, valued at approximately $4,963,180. This represents a 4.31% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Stock Performance

NASDAQ HQY opened at $105.41 on Monday. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62. The company has a 50 day moving average of $96.64 and a 200-day moving average of $87.20. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.81 billion, a price-to-earnings ratio of 39.48, a PEG ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity's revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source